Related Experiment Video
Updated: Oct 17, 2025

05:59
Nasal Wipes for Influenza A Virus Detection and Isolation from Swine
Published on: December 4, 2015
9.6K
The Multilevel Regulation of Complex Policy Problems: Uncertainty and the Swine Flu Pandemic
Summary
This study on pandemic regulation reveals that the World Health Organization (WHO) denied uncertainty, while the European Union openly communicated it. Open communication about uncertainty in multilevel governance was better received.
Area of Science:
- Public Health Policy
- Governance Studies
- Risk Communication
Background:
- Complex policy problems in multilevel governance present significant challenges.
- Understanding how scientific expertise and uncertainty are managed is crucial for effective regulation.
- The H1N1 pandemic of 2009 serves as a critical case for examining these dynamics.
Purpose of the Study:
- To analyze the challenges of tackling complex policy problems within multilevel governance structures.
- To investigate the distinct approaches to uncertainty and scientific expertise in pandemic regulation.
- To compare the regulatory practices of the World Health Organization (WHO) and the European Union (EU).
Main Methods:
- Comparative case study analysis focusing on the H1N1 pandemic (2009).
- Examination of regulatory practices at the global (WHO) and European (EU) levels.
- Analysis of how scientific expertise and uncertainty were communicated and managed.
Main Results:
- A fundamental difference in attitudes toward uncertainty was observed between the WHO and the EU.
- The WHO adopted a 'speaking truth to power' approach, denying uncertainty.
- The EU, conversely, embraced open communication about uncertainty as part of its scientific expertise role.
Conclusions:
- The WHO's denial of uncertainty faced criticism.
- The EU's open communication strategy regarding uncertainty was positively received.
- Effective management and communication of uncertainty are vital for successful multilevel governance in public health crises.
Related Concept Videos
Drug Control Governance: Regulatory Bodies and Their Impact
286
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
286
Global Regulatory Systems
182
Global regulatory systems in bacteria enable rapid and coordinated responses to environmental changes by integrating sensory inputs with gene expression, ensuring efficient adaptation to fluctuating conditions. Key global regulatory mechanisms include regulons, two-component systems, sigma factors, and secondary messengers.Regulons and Global RegulatorsA regulon is a collection of genes and operons controlled by a common global regulator. These regulators enable bacteria to prioritize resource...
182
Drug Regulation
2.1K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.1K
Steps in Outbreak Investigation
256
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
256
Regulation of Expression Occurs at Multiple Steps
3.3K
3.3K
Viral Recombination
24.0K
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
24.0K

